A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
Public ClinicalTrials.gov record NCT03971422. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
Study identification
- NCT ID
- NCT03971422
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- UCB Biopharma SRL
- Industry
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Interventions
- Rozanolixizumab Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2, 2019
- Primary completion
- Aug 30, 2021
- Completion
- Oct 25, 2021
- Last update posted
- Dec 23, 2025
2019 – 2021
United States locations
- U.S. sites
- 30
- U.S. states
- 20
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mg0003 50081 | Phoenix | Arizona | 85013 | — |
| Mg0003 50082 | Scottsdale | Arizona | 85251 | — |
| Mg0003 50072 | Los Angeles | California | 90033 | — |
| Mg0003 50092 | Orange | California | 92868 | — |
| Mg0003 50097 | San Francisco | California | 94109 | — |
| Mg0003 50099 | San Francisco | California | 94117 | — |
| Mg0003 50101 | Aurora | Colorado | 80045 | — |
| Mg0003 50088 | Washington D.C. | District of Columbia | 20037 | — |
| Mg0003 50122 | Miami | Florida | 33136 | — |
| Mg0003 50120 | Miami | Florida | 33144 | — |
| Mg0003 50073 | Tampa | Florida | 33612 | — |
| Mg0003 50075 | Augusta | Georgia | 30912 | — |
| Mg0003 50323 | Honolulu | Hawaii | 96817 | — |
| Mg0003 50109 | Chicago | Illinois | 60637 | — |
| Mg0003 50114 | Indianapolis | Indiana | 46202 | — |
| Mg0003 50074 | Fairway | Kansas | 66205 | — |
| Mg0003 50121 | Lexington | Kentucky | 40536 | — |
| Mg0003 50110 | Ann Arbor | Michigan | 48109 | — |
| Mg0003 50102 | Detroit | Michigan | 48202 | — |
| Mg0003 50104 | Rochester | Minnesota | 55905 | — |
| Mg0003 50105 | St Louis | Missouri | 63110 | — |
| Mg0003 50077 | New York | New York | 10021 | — |
| Mg0003 50117 | Charlotte | North Carolina | 28204 | — |
| Mg0003 50086 | Charlotte | North Carolina | 28207 | — |
| Mg0003 50090 | Winston-Salem | North Carolina | 27157 | — |
| Mg0003 50076 | Columbus | Ohio | 43210 | — |
| Mg0003 50096 | Philadelphia | Pennsylvania | 19104 | — |
| Mg0003 50089 | Philadelphia | Pennsylvania | 19140 | — |
| Mg0003 50084 | Charleston | South Carolina | 29425 | — |
| Mg0003 50113 | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 82 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03971422, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 23, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03971422 live on ClinicalTrials.gov.